2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report

被引：13

作者：

Li, Philip Kam-Tao ^{[1
]}

Bavanandan, Sunita ^{[2
]}

Mohamed, Rosmawati ^{[3
]}

Szeto, Cheuk-Chun ^{[1
]}

Wong, Vincent Wai-Sun ^{[4
,5
]}

Chow, Kai-Ming ^{[1
]}

Dan, Yock-Young ^{[6
]}

Huang, Chiu-Ching ^{[7
,8
]}

Lai, Ching-Lung ^{[9
,10
]}

Tanwandee, Tawesak ^{[11
]}

Teo, Boon Wee ^{[12
]}

Wong, Grace Lai-Hung ^{[4
,5
]}

Yeoh, Eng-Kiong ^{[13
]}

Iseki, Kunitoshi ^{[14
]}

Leung, Chi-Bon ^{[1
]}

Park, Hyeong Cheon ^{[15
]}

Kanjanabuch, Talerngsak ^{[16
,17
]}

Lu, Wanhong ^{[18
]}

Fung, James ^{[8
,9
,10
]}

Jia, Jidong ^{[19
]}

Kanda, Eiichiro ^{[20
]}

Law, Man-Ching ^{[1
]}

Liu, Hong ^{[21
]}

Loo, Ching-Kong ^{[22
]}

Mak, Siu-Ka ^{[22
]}

Lui, Sing-Leung ^{[23
]}

Tang, Hon-Lok ^{[24
]}

Wang, Angela Yee-Moon ^{[9
]}

Yu, Ming-Lung ^{[25
,26
]}

Cheung, Michael ^{[27
]}

Jadoul, Michel ^{[28
]}

机构：

[1] Chinese Univ Hong Kong, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Prince Wales Hosp, Dept Med & Therapeut,Shatin, Hong Kong, Peoples R China

[2] Hosp Kuala Lumpur, Dept Nephrol, Kuala Lumpur, Malaysia

[3] Univ Malaysia, Dept Med, Fac Med, Kuala Lumpur, Malaysia

[4] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Peoples R China

[5] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China

[6] Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Singapore, Singapore

[7] China Med Univ & Hosp, Div Nephrol, Dept Internal Med, Taichung, Taiwan

[8] China Med Univ & Hosp, Kidney Inst, Dept Internal Med, Taichung, Taiwan

[9] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China

[10] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China

[11] Mahidol Univ, Div Gastroenterol & Hepatol, Siriraj Hosp, Dept Internal Med,Fac Med, Bangkok, Thailand

[12] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Div Nephrol, Singapore, Singapore

[13] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China

[14] Tomishiro Cent Hosp, Okinawa, Japan

[15] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea

[16] Chulalongkorn Univ, Ctr Excellence Kidney Metab Disorders, Bangkok, Thailand

[17] Chulalongkorn Univ, Fac Med, Dept Med, Div Nephrol, Bangkok, Thailand

[18] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Nephrol, Coll Med, Xian, Peoples R China

[19] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China

[20] Kawasaki Med Sch, Dept Med Sci, Okayama, Japan

[21] Cent South Univ, Xiangya Hosp 2, Dept Nephrol, Changsha, Peoples R China

[22] Kwong Wah Hosp, Dept Med & Geriatr, Hong Kong, Peoples R China

[23] Tung Wah Hosp, Dept Med, Hong Kong, Peoples R China

[24] Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong, Peoples R China

[25] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan

[26] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan

[27] Kidney Dis Improving Global Outcomes KDIGO, Brussels, Belgium

[28] Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium

来源：

KIDNEY INTERNATIONAL REPORTS | 2020年 / 5卷 / 08期

关键词：

chronic kidney disease; dialysis; direct-acting antiviral; infection control; kidney transplantation; VIRUS-INFECTION; MICRO-ELIMINATION; DIALYSIS PATIENTS; CORE ANTIGEN; HEMODIALYSIS; DACLATASVIR; ASUNAPREVIR; SAFETY; EFFICACY; THERAPY;

D O I：

10.1016/j.ekir.2020.05.001

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

In 2018, Kidney Disease: Improving Global Outcomes (KDIGO) published a clinical practice guideline on the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD). The guideline synthesized recent advances, especially in HCV therapeutics and diagnostics, and provided clinical recommendations and suggestions to aid healthcare providers and improve care for CKD patients with HCV. To gain insight into the extent that the 2018 guideline has been adopted in Asia, KDIGO convened an HCV Implementation Summit in Hong Kong. Participants included nephrologists, hepatologists, and nurse consultants from 8 Southeast Asian countries or regions with comparable high-to-middle economic ranking by the World Bank: mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. Through presentations and discussions, meeting participants described regional practice patterns related to the KDIGO HCV in CKD guideline, identified barriers to implementing the guideline, and developed strategies for overcoming the barriers in Asia and around the world.

引用

页码：1129 / 1138

页数：10

共 50 条

[21] Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Ketteler, Markus
Evenepoel, Pieter
Holden, Rachel M.
Isakova, Tamara
Komaba, Hirotaka
Nickolas, Thomas L.
Sinha, Smeeta
Vervloet, Marc G.
Cheung, Michael
Jorgensen, Hanne Skou
King, Jennifer M.
Grams, Morgan E.
Jadoul, Michel
Moyses, Rosa M. A.
KIDNEY INTERNATIONAL, 2025, 107 (03) : 405 - 423
[22] Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Johansen, Kirsten L.
Garimella, Pranav S.
Hicks, Caitlin W.
Kalra, Philip A.
Kelly, Dearbhla M.
Martens, Sven
Matsushita, Kunihiro
Sarafidis, Pantelis
Sood, Manish M.
Herzog, Charles A.
Cheung, Michael
Jadoul, Michel
Winkelmayer, Wolfgang C.
Reinecke, Holger
KIDNEY INTERNATIONAL, 2021, 100 (01) : 35 - 48
[23] The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Shlipak, Michael G.
Tummalapalli, Sri Lekha
Boulware, L. Ebony
Grams, Morgan E.
Ix, Joachim H.
Jha, Vivekanand
Kengne, Andre-Pascal
Madero, Magdalena
Mihaylova, Borislava
Tangri, Navdeep
Cheung, Michael
Jadoul, Michel
Winkelmayer, Wolfgang C.
Zoungas, Sophia
Abraham, Georgi
Ademi, Zanfina
Alicic, Radica Z.
de Boer, Ian
Deo, Raj
Ding, Xiaoqiang
Ebert, Natalie
Fowler, Kevin J.
Fried, Linda F.
Gansevoort, Ron T.
Garcia-Garcia, Guillermo
Hemmelgarn, Brenda R.
Harding, Jessica Lee
Hudson, Joanna Q.
Iseki, Kunitoshi
Jotwani, Vasantha
Karliner, Leah S.
Levey, Andrew S.
Liew, Adrian
Lin, Peter J.
Luk, Andrea O. Y.
Martinez, Veronica
Moran, Andrew E.
Nguyen, Mai
Obrador, Gregorio T.
O'Donoghue, Donal
Pavkov, Meda E.
Pavlinac, Jessie
Powe, Neil R.
Seegmiller, Jesse C.
Shen, Jenny, I
Shroff, Rukshana
Sol, Laura
Taal, Maarten W.
Tattersall, James
Vassalotti, Joseph A.
KIDNEY INTERNATIONAL, 2021, 99 (01) : 34 - 47
[24] Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective
Jadoul, Michel
Martin, Paul
BLOOD PURIFICATION, 2017, 43 (1-3) : 206 - 209
[25] Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease Introduction
de Boer, Ian H.
Rossing, Peter
KIDNEY INTERNATIONAL, 2020, 98 (04) : S20 - +
[26] The new Kidney Disease: Improving Global Outcomes (KDIGO) guideline for the mineral and bone disorder associated with chronic kidney disease (MBD-CKD)
Drueeke, Tilman B.
NEPHROLOGIE & THERAPEUTIQUE, 2010, 6 (03): : 149 - 150
[27] Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
Gordon, Craig E.
Berenguer, Marina C.
Doss, Wahid
Fabrizi, Fabrizio
Izopet, Jacques
Jha, Vivekanand
Kamar, Nassim
Kasiske, Bertram L.
Lai, Ching-Lung
Morales, Jose M.
Patel, Priti R.
Pol, Stanislas
Silva, Marcelo O.
Balk, Ethan M.
Earley, Amy
Di, Mengyang
Cheung, Michael
Jadoul, Michel
Martin, Paul
ANNALS OF INTERNAL MEDICINE, 2019, 171 (07) : 496 - +
[28] Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Herzog, Charles A.
Asinger, Richard W.
Berger, Alan K.
Charytan, David M.
Diez, Javier
Hart, Robert G.
Eckardt, Kai-Uwe
Kasiske, Bertram L.
McCullough, Peter A.
Passman, Rod S.
DeLoach, Stephanie S.
Pun, Patrick H.
Ritz, Eberhard
KIDNEY INTERNATIONAL, 2011, 80 (06) : 572 - 586
[29] Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Levey, AS
Eckardt, KU
Tsukamoto, Y
Levin, A
Coresh, J
Rossert, J
de Zeeuw, D
Hostetter, TH
Lameire, N
Eknoyan, G
KIDNEY INTERNATIONAL, 2005, 67 (06) : 2089 - 2100
[30] Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
Ostermann, Marlies
Bellomo, Rinaldo
Burdmann, Emmanuel A.
Doi, Kent
Endre, Zoltan H.
Goldstein, Stuart L.
Kane-Gill, Sandra L.
Liu, Kathleen D.
Prowle, John R.
Shaw, Andrew D.
Srisawat, Nattachai
Cheung, Michael
Jadoul, Michel
Winkelmayer, Wolfgang C.
Kellum, John A.
KIDNEY INTERNATIONAL, 2020, 98 (02) : 294 - 309

← 1 2 3 4 5 →